{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"64","upperLimit":"100","value":"73.6"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"53"}],"units":"Participants"}],"description":"Percentage of participants with complete pathologic response. Complete pathologic response is defined as negative local core biopsy or FNA specimens following primary chemo-radiation therapy.","dispersionType":"90% Confidence Interval","groups":[{"description":"Gemcitabine 50 mg/m2 and Cisplatin 40mg/m2 administered weekly throughout IMRT radiation therapy. Gemcitabine will be infused prior to cisplatin and given over approximately 30 minutes while the cisplatin will be delivered over approximately 60 minutes.","id":"OG000","title":"GEM+CIS+IMRT"}],"paramType":"NUMBER","populationDescription":"Eligible and treated","reportingStatus":"POSTED","timeFrame":"6 -8 weeks after completion of chemo-radiation","title":"Complete Pathologic Response","type":"PRIMARY","unitOfMeasure":"percentage of participants"}